A prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19

…, H Koba, H Kasahara, K Yokota… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Favipiravir is an oral broad-spectrum inhibitor of viral RNA-dependent RNA polymerase that
is approved for treatment of influenza in Japan. We conducted a prospective, randomized, …

Iridium complex-catalyzed highly enantio-and diastereoselective [2+ 2+ 2] cycloaddition for the synthesis of axially chiral teraryl compounds

T Shibata, T Fujimoto, K Yokota… - Journal of the American …, 2004 - ACS Publications
An asymmetric [2+2+2] cycloaddition of an α,ω-diyne, possessing ortho-substituted aryl groups
on its terminus, and a monoalkyne with oxygen functionalities gave various axially chiral …

[HTML][HTML] Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide …

…, F Nakamura-Uchiyama, K Yokota… - The Lancet Regional …, 2022 - thelancet.com
Background Before widespread coronavirus disease (COVID-19) vaccinations, Japan
experienced three COVID-19 epidemic waves. This study aimed to evaluate the characteristics of …

Cholangitis with septic shock caused by Raoultella planticola

K Yokota, H Gomi, Y Miura… - Journal of medical …, 2012 - microbiologyresearch.org
Raoultella planticola (formerly Klebsiella planticola) is a Gram-negative bacterium that has
been rarely reported in association with human infection. Here we describe a case of …

[HTML][HTML] Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan

…, M Kondo, K Izumi, M Hojo, T Mizoue, K Yokota… - International Journal of …, 2022 - Elsevier
Objectives To evaluate the effectiveness of remdesivir in the early stage of nonsevere
COVID-19. Although several randomized controlled trials have compared the effectiveness of …

[HTML][HTML] Effectiveness of favipiravir on nonsevere, early-stage COVID-19 in Japan: a large observational study using the COVID-19 registry Japan

…, M Kondo, K Izumi, M Hojo, T Mizoue, K Yokota… - Infectious Diseases and …, 2022 - Springer
Introduction Several randomized controlled trials have compared the effectiveness of
favipiravir with that of placebo. However, evidence regarding its effect on nonsevere, early-stage …

Livedo reticularis associated with COVID-19

T Sahara, K Yokota - Internal Medicine, 2022 - jstage.jst.go.jp
A 57-year-old man was admitted in order to be treated for coronavirus disease 2019 (COVID-19).
He had no past medical history, taking no medications or supplements. He has no …

Synthesis and Biological Activity of PointFluorinated Pheromone Analogues of Eldana saccharina

T Itoh, K Kudo, K Yokota, N Tanaka… - European Journal of …, 2004 - Wiley Online Library
Substitution of fluorine atoms on an organic molecule makes it possible to modify the molecular
orbital and electron density of the surface without changing its molecular shape. Point‐…

Efficacy of remdesivir in hospitalised COVID-19 patients in Japan: a large observational study using the COVID-19 Registry Japan

…, M Kondo, K Izumi, M Hojo, T Mizoue, K Yokota… - medRxiv, 2021 - medrxiv.org
Objectives Results from several randomised controlled trials comparing the efficacy of
remdesivir with placebo have been reported. Data on the efficacy of remdesivir in Asian …

[PDF][PDF] Concurrent COVID-19 and tuberculosis in an immigrant worker presenting with hemoptysis

T Sahara, K Yokota - The American Journal of Tropical Medicine …, 2021 - scienceopen.com
A 59-year-old man was referred to our hospital by a regional public health center for the
treatment of coronavirus disease 2019 (COVID-19), which was diagnosed by the …